I can't speak to the financial; that's in another area. I do support families having things in their households, as we've talked about before, and the items that I've talked about before and that Dr. Kettner has spoken to as well.
On the issue of prioritization--or it's really, again, sequencing of the vaccine--clearly, while the final decisions, which are a collective decision across the country, are not finalized yet, isolated and remote communities are going to be at the top of the list in terms of prioritization because of the nature of health care access. And if you are wrong and they do get sick, they're going to have to be flown out, etc.
In addition, antivirals are already pre-positioned in those communities to provide early treatment. So even in advance of a vaccine, that's in place at the nursing stations and others.
Third, those with underlying risk conditions—we recognize diabetes, pregnancy, etc.— are going to be at the top of the list whether they're aboriginal or non-aboriginal. What we have not been able to sort out scientifically is whether a perfectly healthy person of aboriginal descent is at greater risk or substantially greater risk of developing serious disease with H1N1 for no other reason than that they are aboriginal. That we have not been able to sort out. Even if it is a slightly increased risk, the logistical challenge is in reaching that group other than on reserves, etc., which will be obviously high on the list because it will be one in a thousand, and so you're chasing 999 to try to find that one.
But that having been said, regarding the provincial and territorial plans, the local plans to actually roll it out, you will be going into a community and doing a community. You will not be going into a community and asking, “Do you have diabetes or not?” You're going to do the whole community. So again, from a practical standpoint, once the vaccine is available, people will be getting it. In the meantime, there will be antivirals in order to address that.